In 54 GC patients who underwent preoperative chemotherapy (group A), high SPARC expression after chemotherapy correlated with depth of invasion, lymph node metastasis, and TNM stage (P<0.05) (Table 2). This evidence concerns the gene SPARC and metastatic malignant neoplasm in the lymph nodes.